On ECHEMI
Home > Drugs > Chronic myeloid leukemia in the elderly
Chronic myeloid leukemia in the elderly
Chronic myelocytic leukemia (CML) is an acquired malignant clonal disease of hematopoietic stem cells that occurs frequently in middle-aged people. It mainly involves the myeloid system and is characterized by a persistent and progressive increase in the number of peripheral blood leukocytes and splenomegaly. The course of the disease is relatively slow, and most patients die of acute transformation.
  • Site of disease:

    Bone marrow blood vessels
  • Infectious :

    Not contagious
  • Frequent population:

    Elderly population
  • Related symptoms:

    Splenomegaly Hepatosplenomegaly Leukocytosis Ulcers Abdominal masses
  • Concurrent disease:

Related Drugs
Imatinib Mesylate Tablets
Indication: It is used to treat the chronic phase, accelerated phase or blast phase of Philadelphia chromosome-positive chronic myeloid leukemia (PhCML). (See the inner package insert for details).
Manufacturer:

Jiangsu Hansoh Pharmaceutical Group Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.